ENTITY

Dicerna Pharmaceuticals (DRNA US)

Analysis

Health Care • United States

Dicerna Pharmaceuticals, Inc. provides biopharmaceutical products. The Company discovers and develops ribonucleic acid for the treatment of liver diseases and cancer.

Refresh

No events found

We’ll display events we find for Dicerna Pharmaceuticals here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00